MCID: OBS168
MIFTS: 22

Obsolete: Atypical Teratoid/rhabdoid Tumor

Categories: Rare diseases

Aliases & Classifications for Obsolete: Atypical Teratoid/rhabdoid Tumor

MalaCards integrated aliases for Obsolete: Atypical Teratoid/rhabdoid Tumor:

Name: Obsolete: Atypical Teratoid/rhabdoid Tumor 58
at/rt 58

Classifications:



External Ids:

Orphanet 58 ORPHA251891

Summaries for Obsolete: Atypical Teratoid/rhabdoid Tumor

MalaCards based summary : Obsolete: Atypical Teratoid/rhabdoid Tumor, also known as at/rt, is related to atypical teratoid rhabdoid tumor and rhabdoid tumor predisposition syndrome 1. The drugs Methotrexate and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and liver.

Related Diseases for Obsolete: Atypical Teratoid/rhabdoid Tumor

Diseases related to Obsolete: Atypical Teratoid/rhabdoid Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 17)
# Related Disease Score Top Affiliating Genes
1 atypical teratoid rhabdoid tumor 12.3
2 rhabdoid tumor predisposition syndrome 1 11.6
3 rhabdoid cancer 10.4
4 medulloblastoma 10.1
5 hemangiopericytoma, malignant 9.9
6 astrocytoma 9.9
7 grade iii astrocytoma 9.9
8 lipid metabolism disorder 9.9
9 benign ependymoma 9.9
10 cellular ependymoma 9.9
11 hydrocephalus 9.7
12 ganglioneuroblastoma 9.7
13 mutism 9.7
14 medulloepithelioma 9.7
15 supratentorial primitive neuroectodermal tumor 9.7
16 ependymoblastoma 9.7
17 fatty liver disease 9.7

Graphical network of the top 20 diseases related to Obsolete: Atypical Teratoid/rhabdoid Tumor:



Diseases related to Obsolete: Atypical Teratoid/rhabdoid Tumor

Symptoms & Phenotypes for Obsolete: Atypical Teratoid/rhabdoid Tumor

Drugs & Therapeutics for Obsolete: Atypical Teratoid/rhabdoid Tumor

Drugs for Obsolete: Atypical Teratoid/rhabdoid Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 78)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
2
Cisplatin Approved Phase 3 15663-27-1 84093 441203 2767
3
leucovorin Approved Phase 3 58-05-9 6006 143
4
Etoposide Approved Phase 3 33419-42-0 36462
5
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
6
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
7
Carboplatin Approved Phase 3 41575-94-4 10339178 498142 38904
8
Sargramostim Approved, Investigational Phase 3 123774-72-1, 83869-56-1
9
Levoleucovorin Approved, Investigational Phase 3 68538-85-2
10
Lenograstim Approved, Investigational Phase 3 135968-09-1
11
Thiotepa Approved, Investigational Phase 3 52-24-4 5453
12
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
13
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
14
Emodepside Investigational, Vet_approved Phase 3 155030-63-0
15 Alkylating Agents Phase 3
16 Vitamin B Complex Phase 3
17 Folic Acid Antagonists Phase 3
18 Topoisomerase Inhibitors Phase 3
19 Dermatologic Agents Phase 3
20 Antimitotic Agents Phase 3
21 Vitamin B9 Phase 3
22 Folate Phase 3
23 Immunosuppressive Agents Phase 3
24 Antirheumatic Agents Phase 3
25 Antimetabolites Phase 3
26 Etoposide phosphate Phase 3
27 Immunologic Factors Phase 3
28 Trace Elements Phase 3
29 Vitamins Phase 3
30 Micronutrients Phase 3
31 Hormones Phase 3
32 Podophyllotoxin Phase 3 518-28-5
33 Nutrients Phase 3
34 Adjuvants, Immunologic Phase 3
35 Hematinics Phase 3
36 Calcium, Dietary Phase 3
37 Protective Agents Phase 3
38 Antidotes Phase 3
39
Hydrocortisone acetate Approved, Vet_approved Phase 2 50-03-3
40
Hydrocortisone Approved, Vet_approved Phase 2 50-23-7 5754
41
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
42
Dactinomycin Approved, Investigational Phase 2 50-76-0 2019 457193
43
Cytarabine Approved, Experimental, Investigational Phase 2 147-94-4, 65-46-3 6253
44
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
45
Isotretinoin Approved Phase 2 4759-48-2 5538 5282379
46
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
47
Tyrosine Approved, Investigational, Nutraceutical Phase 2 60-18-4 6057
48
Tretinoin Approved, Investigational, Nutraceutical Phase 2 302-79-4 5538 444795
49
Imidazole Experimental, Investigational Phase 2 288-32-4 795
50 Hydrocortisone hemisuccinate Phase 2

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Systemic Chemotherapy, Second Look Surgery and Conformal Radiation Therapy Limited to the Posterior Fossa and Primary Site for Children >/= to 8 Months and <3 Years With Non-metastatic Medulloblastoma: A Children&Apos;s Oncology Group Phase III Study Completed NCT00006461 Phase 3 cisplatin;cyclophosphamide;vincristine sulfate;etoposide
2 Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System With Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation Active, not recruiting NCT00653068 Phase 3 Carboplatin;Cisplatin;Cyclophosphamide;Etoposide;Leucovorin Calcium;Methotrexate;Thiotepa;Vincristine Sulfate
3 A Prospective, Multicentre Trial on the Value of 18F-FET PET in the Post-therapeutic Evaluation of Childhood Brain Tumours Unknown status NCT03216148 Phase 2
4 A Phase II Study of Intrathecal and Systemic Chemotherapy With Radiation Therapy for Children With Central Nervous System Atypical Teratoid/Rhabdoid Tumor (AT/RT) Tumor Completed NCT00084838 Phase 2 cisplatin;cyclophosphamide;cytarabine;dexrazoxane hydrochloride;doxorubicin hydrochloride;etoposide;leucovorin calcium;methotrexate;temozolomide;therapeutic hydrocortisone;vincristine sulfate;Dactinomycin
5 Phase 2 Study of Alisertib as a Single Agent in Recurrent or Progressive Central Nervous System (CNS) Atypical Teratoid Rhabdoid Tumors (AT/RT) and Extra-CNS Malignant Rhabdoid Tumors (MRT) and in Combination Therapy in Newly Diagnosed AT/RT Recruiting NCT02114229 Phase 2 alisertib;methotrexate;cisplatin;carboplatin;cyclophosphamide;etoposide;topotecan;vincristine
6 A Phase II Study of Intraventricular Methotrexate With Systemic Topotecan and Cyclophosphamide in Children With Recurrent or Progressive Malignant Brain Tumors Active, not recruiting NCT02684071 Phase 2 Intra thecal methotrexate;topotecan;cyclophosphamide
7 NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Active, not recruiting NCT00528437 Phase 2 temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
8 A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas Active, not recruiting NCT01188096 Phase 2 Poly ICLC
9 Phase I Study of Methotrexate Infusion Into the Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors Completed NCT02458339 Phase 1 Methotrexate
10 Vitrification Versus Slow Freezing of Human Day 3 Embryos Unknown status NCT00710723
11 Effects of Combined Resistance and Aerobic Training vs Aerobic Training on Cognition and Mobility Following Stroke Completed NCT01712724
12 Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes Completed NCT00458133
13 Cardiovascular and Cardiorespiratory Coupling After Different Types of Training and Detraining Completed NCT02441192
14 Enhancing Cognition and Functional Independence in Senior Women With Mild Cognitive Impairment: A Randomized Trial of Aerobic vs. Resistance Training Completed NCT00958867
15 Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study Completed NCT01737671 Early Phase 1 Methotrexate;Leucovorin
16 The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis Recruiting NCT04175457
17 Fetal Early Non-invasive Biomarkers of Chronic Maternal Stress During Pregnancy Resulting in Alterations of Infant Cognitive Development Recruiting NCT03389178
18 A Multi-centre, Controlled, Prospective Cohort Study Investigating the Accuracy of the Glycologic Limited Test Kit to Detect Bacterial Infection in Chronic and Delayed-healing Wounds. Recruiting NCT03883230
19 Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection Not yet recruiting NCT03586206

Search NIH Clinical Center for Obsolete: Atypical Teratoid/rhabdoid Tumor

Genetic Tests for Obsolete: Atypical Teratoid/rhabdoid Tumor

Anatomical Context for Obsolete: Atypical Teratoid/rhabdoid Tumor

MalaCards organs/tissues related to Obsolete: Atypical Teratoid/rhabdoid Tumor:

40
Brain, Testes, Liver, Whole Blood, Prostate, Breast, Eye

Publications for Obsolete: Atypical Teratoid/rhabdoid Tumor

Articles related to Obsolete: Atypical Teratoid/rhabdoid Tumor:

(show top 50) (show all 1404)
# Title Authors PMID Year
1
A study on the spectral, microstructural, and magnetic properties of Eu-Nd double-substituted Ba0.5Sr0.5Fe12O19 hexaferrites synthesized by an ultrasonic-assisted approach. 61
31810870 2020
2
Sonochemical synthesis of Dy3+ substituted Mn0.5Zn0.5Fe2-xO4 nanoparticles: Structural, magnetic and optical characterizations. 61
31683234 2020
3
The Impact of Distinct Exercise Training Modalities on Echocardiographic Measurements in Patients with Heart Failure with Reduced Ejection Fraction. 61
31812550 2020
4
[nat/44Sc(pypa)]-: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate. 61
31976659 2020
5
Effects of storage time prolongation on in vivo and in vitro characteristics of 4°C-stored platelets. 61
32017135 2020
6
p-p Heterojunction Sensors of p-Cu3Mo2O9 Micro/Nanorods Vertically Grown on p-CuO Layers for Room-Temperature Ultrasensitive and Fast Recoverable Detection of NO2. 61
31976643 2020
7
Optimal conditions for the storage of German cockroach extract. 61
31789410 2020
8
Manipulating On/Off Single-Molecule Magnet Behavior in a Dy(III)-Based Photochromic Complex. 61
31955567 2020
9
Development, characterization and stability evaluation of ciprofloxacin-loaded parenteral nutrition nanoemulsions. 61
31967908 2020
10
Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy. 61
31682308 2020
11
Preliminary investigation on feline coronavirus presence in the reproductive tract of the tom cat as a potential route of viral transmission. 61
30900940 2020
12
Custom selected reference genes outperform pre-defined reference genes in transcriptomic analysis. 61
31924161 2020
13
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors. 61
31504799 2020
14
Aerobic and resistance training enhances endothelial progenitor cell function via upregulation of caveolin-1 in mice with type 2 diabetes. 61
31900223 2020
15
Stability of extracts from pollens of allergenic importance in Korea. 61
31534112 2020
16
Impact of Double- or Triple-Hit Pathology on Rates and Durability of Radiation Therapy Response Among Patients With Relapsed or Refractory Large B-Cell Lymphoma. 61
31585205 2020
17
Oxidation Behaviors of Co, Cr, and Ni Nanopowders: A Real-Time Synchrotron X-ray Scattering Study. 61
31383172 2020
18
Nonviral polymeric nanoparticles for gene therapy in pediatric CNS malignancies. 61
31655205 2020
19
SWI/SNF complex heterogeneity relates with polyphenotypic differentiation, prognosis and immune response in rhabdoid tumors. 61
31912158 2020
20
Model-based process development of continuous chromatography for antibody capture: A case study with twin-column system. 61
32037074 2020
21
Measurement of Fracture Toughness of Pure Tungsten Using a Small-Sized Compact Tension Specimen. 61
31935899 2020
22
The challenge of post-mortem GHB analysis: storage conditions and specimen types are both important. 61
31598775 2020
23
Ageing Behaviour of Al-Mg-Si Alloys After Cryogenic and Room Temperature Deformation. 61
31979360 2020
24
Effect of Reaction Temperature on Shape Evolution of Palladium Nanoparticles and Their Cytotoxicity against A-549 Lung Cancer Cells. 61
31891061 2019
25
Interactions between Mutant Bacterial Lipopolysaccharide (LPS-Ra) Surface Layers: Surface Vesicles, Membrane Fusion, and Effect of Ca2+and Temperature. 61
31604373 2019
26
Superior triethylamine detection at room temperature by {-112} faceted WO3 gas sensor. 61
31325692 2019
27
Morphology and kinetics of asphalt binder microstructure at gas, liquid and solid interfaces. 61
31696508 2019
28
Unusual Magneto-structural Features of the Halo-Substituted Materials [FeIII(5-X-salMeen)2]Y: a Cooperative [HS-HS] ↔ [HS-LS] Spin Transition. 61
31826307 2019
29
Origin of the Breakthrough Productivity of Ruthenium-Cyclic Alkyl Amino Carbene Catalysts in Olefin Metathesis. 61
31771327 2019
30
Minor compositional alterations in faecal microbiota after five weeks and five months storage at room temperature on filter papers. 61
31831829 2019
31
Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection. 61
30838551 2019
32
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma. 61
31873931 2019
33
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis. 61
31464041 2019
34
Conformation controls mobility: 2H-Tetranaphthylporphyrins on Cu(111). 61
31808603 2019
35
Bond durability when applying phosphate ester monomer-containing primers vs. self-adhesive resin cements to zirconia: Evaluation after different aging conditions. 61
31690540 2019
36
Microscopic origin of multiple exciton emission in low-dimensional lead halide perovskites. 61
31731850 2019
37
Structural, magnetic, optical properties and cation distribution of nanosized Co0.7Zn0.3TmxFe2-xO4 (0.0 ≤ x ≤ 0.04) spinel ferrites synthesized by ultrasonic irradiation. 61
31450320 2019
38
Sonochemical synthesis of Eu3+ substituted CoFe2O4 nanoparticles and their structural, optical and magnetic properties. 61
31450366 2019
39
Schwannoma arising in mediastinal lymph node diagnosed by endobronchial ultrasound. 61
31452898 2019
40
Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review. 61
31707588 2019
41
Variability of cytokine concentration in whole blood serum and bronchoalveolar lavage over time. 61
31276936 2019
42
Adult Atypical Teratoid/Rhabdoid Tumor in the Pineal Region: Case Report and Literature Review. 61
31759153 2019
43
Neoadjuvant chemotherapy for atypical teratoid rhabdoid tumors (AT/RTs). 61
31745641 2019
44
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904). 61
31185328 2019
45
Encapsulation of human limbus-derived stromal/mesenchymal stem cells for biological preservation and transportation in extreme Indian conditions for clinical use. 61
31740778 2019
46
Syntheses of Benzofuranoquinolines and Analogues via Photoinduced Acceptorless Dehydrogenative Annulation of o-Phenylfuranylpyridines. 61
31686513 2019
47
2  mJ room temperature Fe:CdTe laser tunable from 5.1 to 6.3  μm. 61
31730081 2019
48
Ultrasensitive resistivity-based ethanol sensor based on the use of CeO2-Fe2O3 core-shell microclusters. 61
31650364 2019
49
Structural, magnetic, optical properties and cation distribution of nanosized Ni0.3Cu0.3Zn0.4TmxFe2-xO4 (0.0 ≤ x ≤ 0.10) spinel ferrites synthesized by ultrasound irradiation. 61
31085087 2019
50
Stability of epidermal growth factor, fibronectin, and alpha-2-macroglobulin in canine serum under different storage conditions. 61
31571726 2019

Variations for Obsolete: Atypical Teratoid/rhabdoid Tumor

Expression for Obsolete: Atypical Teratoid/rhabdoid Tumor

Search GEO for disease gene expression data for Obsolete: Atypical Teratoid/rhabdoid Tumor.

Pathways for Obsolete: Atypical Teratoid/rhabdoid Tumor

GO Terms for Obsolete: Atypical Teratoid/rhabdoid Tumor

Sources for Obsolete: Atypical Teratoid/rhabdoid Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....